TPB Acquisition, a blank check company formed by venture foundry The Production Board targeting sustainable businesses in food and bio, filed on Friday with the SEC for an initial public offering.
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2020
In this edition of Orrick’s series of life sciences publications, the traditional update on broader venture market financing data is included, depicting the macro-level trends of interest. In addition, given their surge in popularity, SPACs and their particular utility to life sciences businesses are the subject of this edition’s spotlight.
Life sciences SPAC HighCape Capital Acquisition prices $100 million IPO at $10
HighCape Capital Acquisition, a blank check company formed by HighCape Capital targeting the life sciences industry, raised $100 million by offering 10 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. The company originally planned to offer half-warrants.